Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A study in healthy men to test how bosentan influences the amount of nerandomilast in the blood Ended

2025-521104-21-00 Healthy volunteer trial 2025-08-22
A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144 Ended

2025-521924-31-00 locally advanced or metastatic HR+/HER2- breast cancer 2025-08-20
A Phase 1, Single-Center, Open-Label, Fixed-Sequence, 2-Part Study to Assess the Pharmacokinetics of IMU-838 Administered Alone and in Combi… Ended

2025-521754-41-00 Multiple sclerosis 2025-08-15
A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended

2024-518696-65-00 (HR) -positive human epidermal growth factor receptor 2 2025-08-12
A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood Ended

2025-521279-30-00 Healthy volunteer trial 2025-08-06
Cardiovascular safety assessment of Tanimilast in healthy volunteers Ended

2024-516861-35-00 This is Phase I study to assess the effect on the heart 2025-07-31
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Adaptive Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Phar… Ended

2025-521914-25-00 Schizophrenia 2025-07-31
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body Ended

2025-521419-37-00 Healthy volunteer trial 2025-07-22
A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time Ended

2025-521705-40-00 Fibrostenotic Crohn’s disease 2025-07-18
A study to test a single administration of three dose levels of ATX101 in healthy adults. Ended

2025-521999-56-00 Treatment of vascular hyperpermeability in patients wit 2025-07-16
The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune D… Ended

2024-518797-13-00 systemic lupus erythematosus [SLE]/lupus nephritis [LN] 2025-07-10
Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by A… Ended

2025-521783-35-00 Influenza virus 2025-07-10
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults Ended

2025-520558-12-00 Clonal hematopoiesis 2025-07-09
A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump. Ended

2024-520230-29-00 Diabetes mellitus type 2 2025-07-01
A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together Ended

2024-518103-21-00 Healthy volunteer trial 2025-06-30
Pharmacokinetic study of colistimethate sodium Ended

2024-520019-41-00 serious infections caused by selected aerobic gram-nega 2025-06-30
A phase 1, double-blind, placebo-controlled, randomized, single ascending dose and multiple ascending dose study to assess the safety, toler… Ended

2024-519813-74-00 Adult polyglucosan body disease (APBD). 2025-06-27
A study to examine the effects of oral NTX-1955 on the brain in healthy adults. Ended

2025-521829-32-00 Generalized Anxiety Disorder (GAD) 2025-06-24
A study to learn how the study medicine called [14C]PF-07054894 is processed by the body. Ended

2024-519882-23-00 Inflammatory bowel disease. 2025-06-13
A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors Ended

2024-513692-41-00 advanced solid malignancies 2025-06-11
A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1… Ended

2025-521615-39-00 not applicable (submitted trial is a pharmacokinetic an 2025-06-04
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia Ended

2024-518471-63-00 Type 2 Diabetes Mellitus 2025-06-03
A study to investigate how different tablet types of balinatunfib and food will influence the absorption of balinatunfib in blood in healthy… Ended

2024-519860-41-00 Immune system diseases 2025-06-02
PainCart Study Evaluating the Analgesic Profile of SAGE-319 Ended

2025-521380-12-00 Disorders characterized by a deficit in GABAergic signa 2025-06-02